Exploring cancer genomic data from the cancer genome atlas project
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The Cancer Genome Atlas (TCGA) has compiled genomic, epigenomic, and proteomic data from more than 10,000 samples derived from 33 types of cancer, aiming to improve our understanding of the molecular basis of cancer development. Availability of these genome-wide information provides an unprecedented opportunity for uncovering new key regulators of signaling pathways or new roles of pre-existing members in pathways. To take advantage of the advancement, it will be necessary to learn systematic approaches that can help to uncover novel genes reflecting genetic alterations, prognosis, or response to treatments. This minireview describes the updated status of TCGA project and explains how to use TCGA data.
Abstract
The Cancer Genome Atlas (TCGA) has compiled genomic, epigenomic, and proteomic data from more than 10,000 samples derived from 33 types of cancer, aiming to improve our understanding of the molecular basis of cancer development. Availability of these genome-wide information provides an unprecedented opportunity for uncovering new key regulators of signaling pathways or new roles of pre-existing members in pathways. To take advantage of the advancement, it will be necessary to learn systematic approaches that can help to uncover novel genes reflecting genetic alterations, prognosis, or response to treatments. This minireview describes the updated status of TCGA project and explains how to use TCGA data.
참고문헌 (20)
- Consortium IHGS, "Finishing the euchromatic sequence of the human genome", Nature, 431, pp.931~945 (2004)
- Lander ES, "Initial sequencing and analysis of the human genome", Nature, 409, pp.860~921 (2001)
- Venter JC, "The sequence of the human genome", Science, 291, pp.1304~1351 (2001)
- DeNicola GM, "NRF2regulates serine biosynthesis in non-small cell lung cancer", Nat Genet, 47, pp.1475~1481 (2015)
- Park YY, "Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer", EMBO Mol Med, 4, pp.52~67 (2012)
- Saha SK, "Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer", Nature, 513, pp.110~114 (2014)
- Cancer Genome Atlas Research Network, "Comprehensive genomic characterization defines human glioblastoma genes and core pathways", Nature, 455, pp.1061~1068 (2008)
- International Cancer Genome Consortium, "International network of cancer genome projects", Nature, 464, pp.993~998 (2010)
- Cancer Genome Atlas Research Network, "Integrated genomic analyses of ovarian carcinoma", Nature, 474, pp.609~615 (2011)
- Cancer Genome Atlas Research Network, "Comprehensive genomic characterization of squamous cell lung cancers", Nature, 489, pp.519~525 (2012)
- Cancer Genome Atlas Research Network, "Comprehensive molecular characterization of human colon and rectal cancer", Nature, 487, pp.330~337 (2012)
- Han L, "The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers", Cancer Cell, 28, pp.515~528 (2015)
- Yates LA, "The long and short of microRNA", Cell, 153, pp.516~519 (2013)
- Spurrier B, "Reverse-phase protein lysate microarrays for cell signaling analysis", Nat Protoc, 3, pp.1796~1808 (2008)
- Gutman DA, "Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data", J Am Med Inform Assoc, 20, pp.1091~1098 (2013)
- Clark K, "The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository", J Digit Imaging, 26, pp.1045~1057 (2013)
- Cerami E, "The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data", Cancer Discov, 2, pp.401~404 (2012)
- Goswami CP, "PROGgeneV2 : enhancements on the existing database", BMC Cancer, 14, pp.970~ (2014)
- Koch A, "MEXPRESS : visualizing expression, DNA methylation and clinical TCGA data", BMC Genomics, 16, pp.636~ (2015)
- Li J, "TCPA : a resource for cancer functional proteomics data", Nat Methods, 10, pp.1046~1047 (2013)